Navigation Links
SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)
Date:6/5/2008

the MHI fully supports the idea that HDL-based therapies are potentially the next frontier in the battle against cardiovascular disease".

"Apo AI(Milano) is a drug candidate with outstanding clinical and commercial potential," said Andrew Baum, president and chief executive officer of SemBioSys. "Manufacturing challenges have been a major impediment to drug development efforts. We have now shown that safflower Apo AI(Milano), which we believe can be produced in a cost effective manner, has the potential to allow for the full development and commercialization of this drug candidate. We expect that the data we have previously generated, together with the latest animal model data, will greatly facilitate and accelerate our partnership efforts for this program."

About Apo AI/Apo AI(Milano)

Apo AI is a naturally occurring human protein being developed as a cardiovascular therapy to stabilize and reverse atherosclerotic plaque deposition for the prevention and treatment of cardiovascular disease. Apo AI is believed by many clinicians to be the archetype for a new generation of cardiovascular drugs (HDL therapies). Apo AI is the major apolipoprotein associated with HDL, commonly referred to as "good cholesterol", which naturally removes plaque from arteries. Published studies have shown that Apo AI(Milano), which is a variant of Apo AI, in a phospholipid formulation could reduce plaque volume at a level and speed unattainable with any current drug therapy. If successfully commercialized, predicted high dosing (multiple grams per course of patient treatment) coupled with a large patient population would be expected to drive volume demand of several tons of Apo AI(Milano) per year, underscoring the value of a highly scalable, plant manufacturing solution. SemBioSys' proprietary safflower derived Apo AI(Milano) is a des I, 2 variant of Apo AI(Milano) as previously described in the literature.

About Cardiovascular Disease

Atherosclerotic card
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. SemBioSys to present at the Needham & Company Biotechnology and Medical Technology Conference
2. SemBioSys provides update on shrimp feed additive, Immunosphere(TM)
3. SemBioSys announces first quarter 2008 financial and operational results
4. SemBioSys receives milestone payments from AVAC Ltd.
5. SemBioSys initiates toxicology study for safflower-produced insulin
6. SemBioSys announces 2007 financial and operational results
7. SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil
8. SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
9. SemBioSys to present at the 10th Annual BIO CEO & Investor Conference
10. SemBioSys signs option agreement for safflower-produced food ingredient
11. SemBioSys announces 2007 third quarter results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Fla. , Dec. 23, 2014  Rock Creek ... that it has filed a Clinical Trial Application (CTA) ... Healthcare products Regulatory Agency (MHRA) seeking regulatory approval to ... lead molecule, Anatabine Citrate. Contingent on the ... conduct a Phase I trial to assess the safety, ...
(Date:12/22/2014)... - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), ... development of autologous cell therapies, announced today the publication ... in conjunction with co-authors from Kyoto University and the ... ongoing clinical research using dermal sheath cup (DSC) cells ... The paper entitled " Hair Follicle Dermal Stem Cells ...
(Date:12/22/2014)... The American Journal of Hematology/Oncology, ... and editorials addressing developments and pathways related to ... provocative article exploring the role of follicle-stimulating hormone ... of prostate cancer. , The article references ... that there could be a connection to prostate ...
(Date:12/19/2014)... Charm Sciences is pleased to announce that its ... M1 in raw commingled milk is the first lateral ... peer reviewed report of the validation by Technology and ... Fisheries Research (ILVO-T&V) has been published by the Taylor ... toxic aflatoxin and a known carcinogen, can be passed ...
Breaking Biology Technology:Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2
... Services; Tom Still, Wisconsin Technology Council; Tommy G. Thompson, ... at Arusha National Park near Mt. Kilimanjaro in Tanzania ... former Wisconsin Gov. Tommy Thompson skips a second term ... of Health of Human Services will include some worthy ...
... Wis. A simulated supply line in a new ... against actual supply-chain equipment and software. , , Catalyst International ... of Sussex, built the facility, named the Star Alliance Center, ... ,In the marketplace, I dont think theres anybody whos been ...
... Charles Rathmann is a founding partner in communications firm ... on his experiences with two clients. , ,Wisconsin ... in the Far East, creating a demand for Asian ... can be time-consuming and costly, but technology such as ...
Cached Biology Technology:Thompson's HHS legacy will include efforts to combat disease in Africa 2Thompson's HHS legacy will include efforts to combat disease in Africa 3Test center for RFID capabilities opens next week 2Lack of broadband hamstrings international videoconferencing 2Lack of broadband hamstrings international videoconferencing 3
(Date:12/22/2014)... Research and Markets ( ... the "The Global Watermarking and Fingerprinting ... http://photos.prnewswire.com/prnh/20130307/600769 ... the global digital media watermarking and fingerprinting ... piracy by securely and invisibly embedding identifiable ...
(Date:12/19/2014)... and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ) has announced ... America Perimeter Security Systems Market" report to their ... The North American perimeter security market is estimated ... to 2019. Although the U.S. market holds a larger ... is expected to grow at a higher CAGR of ...
(Date:12/17/2014)... , Dec. 15, 2014 Research and Markets ... addition of the "Samsung Galaxy S5 - ... report to their offering. ... totally different sensing technology than the iPhone 5S, ... sensor in its product. The Galaxy ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2
... go a little gooey, but it,s not turning mums, brains ... National University. The study conducted by the Centre ... despite fears mothers may have that pregnancy affects their cognitive ... The findings have been released as part of Mental Health ...
... Aware, Inc. (Nasdaq:,AWRE), a leading supplier of broadband technology ... the company,s operating results,for the third quarter of 2008 ... CEO Michael Tzannes and CFO Rick Moberg will host ... by Thomson and can be accessed on the,Investor Relations ...
... have generated a digital zebrafish embryo - the first ... developed microscope scientists could for the first time track ... life of a zebrafish. The data was reconstructed into ... published in the current online issue of Science ...
Cached Biology News:Pregnancy not turning minds to mush: Study 2Aware Announces Q3 2008 Earnings Conference Call 2Digital zebrafish embryo provides the first complete developmental blueprint of a vertebrate 2
... Markers, 37 kBq, 1 uCi. Carbon-14 radiolabelled ... the sample on Western blots.The Rainbow-labeled version ... in the gel and on the blot.The ... Rainbow-labeling is 0.37-3.7 MBq/mg (10-100 uCi/mg) or ...
NM522 contains an F episome, which is required for production of ssDNA and for blue/white color selection. To maintain the F, NM522 should be grown on minimal (M-9) medium....
... Zero Blunt TOPO PCR ... is designed for cloning ... blunt-end PCR products. The ... TOPO Cloning and greater ...
... 1 EA. Ultrospec 6300 pro ... of the Pharmacopoeia in terms of instrument ... of being able to be used for ... and excellent scanning capability., *Press to read ...
Biology Products: